Home/Filings/4/0001213900-23-096606
4//SEC Filing

Weisblum Eric 4

Accession 0001213900-23-096606

CIK 0001514183other

Filed

Dec 17, 7:00 PM ET

Accepted

Dec 18, 7:44 PM ET

Size

6.8 KB

Accession

0001213900-23-096606

Insider Transaction Report

Form 4
Period: 2023-12-14
Weisblum Eric
DirectorPres, Chief Compliance Officer
Transactions
  • Purchase

    Common Stock

    2023-12-14$1.50/sh+200$300168,324 total
  • Purchase

    Common Stock

    2023-12-15$1.52/sh+900$1,368169,224 total
Footnotes (1)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.51 to $1.52. The reporting person undertakes to provide Silo Pharma, Inc., any security holder of Silo Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Documents

1 file

Issuer

Silo Pharma, Inc.

CIK 0001514183

Entity typeother

Related Parties

1
  • filerCIK 0001569077

Filing Metadata

Form type
4
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 7:44 PM ET
Size
6.8 KB